Clinical Trial Update: Evaluation of Bortezomib Induced Peripheral Neuropathy of Multiple Myeloma (MM) Patients [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating bortezomib-induced peripheral neuropathy in patients with multiple myeloma; the project status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Peripheral Neuropathy

Drugs mentioned

• Velcade (bortezomib)

Snippet

Sponsor: Wolfson Medical Center | Conditions: Multiple Myeloma, Peripheral Neuropathy | Phase 3 | Status: UNKNOWN